Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found 71 genetic regions linked to male pattern baldness, which account for 38% of its genetic risk.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Molybdenum oxide nanozymes can effectively treat and monitor acute kidney injury by reducing oxidative stress.

Mutations in the hairless gene in mice affect its expression and lead to a range of developmental issues in multiple tissues.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Microneedles offer a promising, painless way to treat skin diseases but need improvements for better use.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

Genes play a significant role in male-pattern baldness, and understanding them could lead to new treatments and insights into related health issues.

Using patients' own fat-derived cells to treat alopecia areata significantly improved hair growth and was safe.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Hair follicle regeneration possible, more research needed.

Hormone therapy and surgeries for transgender individuals affect their skin and hair, requiring specific dermatologic treatments and respectful care.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

RADA16 is a promising material for tissue repair and regenerative medicine but needs improvement in strength and cost.

50-nm nanoparticles are better at penetrating skin and targeting hair follicles for drug delivery than 100-nm ones.

Genetic differences affect COVID-19 severity and treatment development.

Higher BMI links to worse hair loss in Taiwanese men.

Genetic and environmental factors, like smoking and exercise, affect male hair loss.

The debate on direct-to-consumer pharmaceutical ads continues, with consumers finding them educational and doctors concerned about their impact on patient relationships and medication understanding.

The study developed a tool to predict how gut microbes process foods and drugs, showing that similar compounds often share metabolic pathways and effects.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

Bone-marrow and epidermal stem cells help heal wounds differently, with bone-marrow cells aiding in blood vessel formation and epidermal cells in hair growth.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Microencapsulation helps protect and track therapeutic cells, showing promise for treating various diseases, but more work is needed to improve the technology.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.